These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37608419)

  • 81. Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.
    Iwatsuki M; Orita H; Kobayashi K; Hidaka S; Arigami T; Kusumoto T; Satake H; Oki E; Tsutsumi S; Tobimatsu K; Shimokawa M; Saeki H; Makiyama A; Baba H; Mori M
    Gastric Cancer; 2022 Jan; 25(1):180-187. PubMed ID: 34379229
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction.
    Yoshikawa T; Takeuchi H; Hasegawa S; Nozaki I; Kishi K; Ito S; Ohi M; Mine S; Hara J; Matsuda T; Hiki N; Kurokawa Y
    Gastric Cancer; 2016 Jan; 19(1):143-9. PubMed ID: 25414051
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [A Case of Esophagogastric Junction Adenocarcinoma with Neuroendocrine Differentiation].
    Kitano Y; Kinoshita J; Oyama K; Okamoto K; Sakai S; Makino I; Nakamura K; Hayashi H; Inokuchi M; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1226-1228. PubMed ID: 29394589
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [A Case in Which pCR Was Obtained by S-1 plus Oxaliplatin Therapy Administered as Neoadjuvant Chemotherapy for Advanced Gastric Cancer].
    Miyamoto H; Hirakawa T; Morimoto J; Nakazawa K; Okada T; Tsujio G; Kurihara S; Aomatsu N; Iwauchi T; Yamagata S; Uchima Y; Takeuchi K
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2030-2032. PubMed ID: 32157049
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
    Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
    J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Surgical considerations in the treatment of gastric cancer.
    Blakely AM; Miner TJ
    Gastroenterol Clin North Am; 2013 Jun; 42(2):337-57. PubMed ID: 23639644
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [A Successful Treatment for Stage III c Gastric Cancer with Low Cardiac Function Using S-1 plus Oxaliplatin(SOX)as a Neoadjuvant Chemotherapy].
    Terashima T; Kawamoto S; Maekawa K; Kuroki N
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1892-1894. PubMed ID: 29394811
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Curatively Resected Stage ⅣGastric Cancer with Positive Peritoneal Cytology Due to SOX Therapy-A Case Report].
    Funamizu N; Kobayashi M; Dairaku K; Hiramoto Y; Tomori K; Iida T; Kurihara K; Nakabayashi Y
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):71-74. PubMed ID: 30765646
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction.
    Klevebro F; Alexandersson von Döbeln G; Wang N; Johnsen G; Jacobsen AB; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M
    Ann Oncol; 2016 Apr; 27(4):660-7. PubMed ID: 26782957
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
    Kurokawa Y; Takeuchi H; Doki Y; Mine S; Terashima M; Yasuda T; Yoshida K; Daiko H; Sakuramoto S; Yoshikawa T; Kunisaki C; Seto Y; Tamura S; Shimokawa T; Sano T; Kitagawa Y
    Ann Surg; 2021 Jul; 274(1):120-127. PubMed ID: 31404008
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas.
    Reim D; Novotny A; Friess H; Slotta-Huspenina J; Weichert W; Ott K; Dislich B; Lorenzen S; Becker K; Langer R
    J Pathol Clin Res; 2020 Oct; 6(4):263-272. PubMed ID: 32401432
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial.
    Shi J; Li N; Tang Y; Jiang L; Yang L; Wang S; Song Y; Liu Y; Fang H; Lu N; Qi S; Chen B; Li Z; Liu S; Wang J; Wang W; Zhu S; Yang J; Li Y; Zhao D; Jin J
    BMC Gastroenterol; 2022 Jul; 22(1):359. PubMed ID: 35902798
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Minimally invasive abdominal and left thoracic approach for esophagogastric junction adenocarcinoma with esophageal diverticulum: A case report.
    Takeuchi Y; Ebihara Y; Nakanishi Y; Asano T; Noji T; Kurashima Y; Murakami S; Nakamura T; Tsuchikawa T; Okamura K; Shichinohe T; Hirano S
    Asian J Endosc Surg; 2019 Apr; 12(2):167-170. PubMed ID: 29888543
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS; Ahn JY; Yook JH; Kim BS
    World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
    Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Experience with chemotherapy for postoperative metastases of adenosquamous carcinoma of the esophagogastric junction and pathological study of its development.
    Mita K; Oda H; Shimaguchi M; Kouno M; Toyota N; Hatano M; Toyota T; Sasaki J
    J Surg Case Rep; 2024 Jul; 2024(7):rjae440. PubMed ID: 38962377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.